Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient

Sodium-glucose cotransporter 2 inhibitors (SGLT2i), initially born as anti-diabetic drugs, have shown many beneficial effects on the cardiovascular system, in particular against heart failure (HF). HF is a complex and multifaceted disease that requires a comprehensive approach. It should not be cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Severino, Paolo, D’Amato, Andrea, Prosperi, Silvia, Costi, Bettina, Angotti, Danilo, Birtolo, Lucia Ilaria, Chimenti, Cristina, Lavalle, Carlo, Maestrini, Viviana, Mancone, Massimo, Fedele, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140096/
https://www.ncbi.nlm.nih.gov/pubmed/34654997
http://dx.doi.org/10.1007/s10741-021-10170-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140096/
https://www.ncbi.nlm.nih.gov/pubmed/34654997
http://dx.doi.org/10.1007/s10741-021-10170-1

Ejemplares similares